Search

Search Constraints

You searched for: Author/Creator Chan, Angela

Search Results

2. Association of age with differences in immune related adverse events and survival of patients with advanced nonsmall cell lung cancer receiving pembrolizumab or nivolumab. Issue 5 (June 2020)

3. Designing and Implementing a Zero Harm Falls Prevention Program: A Quality Improvement Study. Issue 3 (4th July 2022)

6. Immune related adverse events and treatment discontinuation in patients older and younger than 75 years with advanced melanoma receiving nivolumab or pembrolizumab. Issue 2 (March 2022)

7. Implementation of a pooled surveillance testing program for asymptomatic SARS-CoV-2 infections in K-12 schools and universities. (August 2021)

10. Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practice. (July 2019)